The DOI matches its Crossref record.
Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans
Open accessAbstract
African Americans have high incidence rates of end-stage renal disease (ESRD) labeled as due to hypertension. As recent studies showed strong association with idiopathic and HIV-related focal segmental glomerulosclerosis and non-muscle myosin heavy chain 9 (MYH9) gene polymorphisms in this ethnic group, we tested for MYH9 associations in a variety of kidney diseases. Fifteen MYH9 single-nucleotide polymorphisms were evaluated in 175 African Americans with chronic glomerulonephritis-associated ESRD, 696 African Americans reportedly with hypertension-associated ESRD, and 948 control subjects without kidney disease. Significant associations were detected with 14 of the 15 polymorphisms in all 871 non-diabetic patients with ESRD. In hypertension-associated ESRD cases alone, significant associations were found with 13 MYH9 polymorphisms and the previously reported E1 haplotype. Thus, hypertension-associated ESRD in African Americans is substantially related to MYH9 gene polymorphisms and this may explain the poor response to blood pressure control in those diagnosed with hypertensive nephrosclerosis. It is possible that many African Americans classified as having hypertension-associated ESRD have occult MYH9-associated segmental or global glomerulosclerosis. Our study shows that gene-environment and/or gene–gene interactions may initiate kidney disease in genetically susceptible individuals, because African Americans homozygous for MYH9 risk alleles do not universally develop kidney disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Thompson, M. A., Aberg, J. A., Hoy, J. F., Telenti, A., Benson, C., Cahn, P., Eron, J. J., Günthard, H. F., Hammer, S. M., Reiss, P., et al. (2012) · JAMA · doi:10.1001/jama.2012.7961 · Cited by 2,469
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Genovese, G., Friedman, D. J., Ross, M. D., Lecordier, L., Uzureau, P., Freedman, B. I., Bowden, D. W., Langefeld, C. D., Oleksyk, T. K., Uscinski Knob, A. L., et al. (2010) · Science · doi:10.1126/science.1193032 · Cited by 2,028
“Next, we tested association of APOL1 variants and renal disease in a larger cohort of 1030AfricanAmerican cases with H-ESKD and 1025 geographically matched African-American controls from the southeastern United States (7).”
Self-citationA Genome-Wide Association Search for Type 2 Diabetes Genes in African Americans
Palmer, N. D., McDonough, C. W., Hicks, P. J., Roh, B. H., Wing, M. R., An, S. S., Hester, J. M., Cooke, J. N., Bostrom, M. A., Rudock, M. E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029202 · Cited by 1,799
Self-citationTzur, S., Rosset, S., Shemer, R., Yudkovsky, G., Selig, S., Tarekegn, A., Bekele, E., Bradman, N., Wasser, W. G., Behar, D. M., et al. (2010) · Human Genetics · doi:10.1007/s00439-010-0861-0 · Cited by 653
Diabetic Microvascular Disease: An Endocrine Society Scientific Statement
Barrett, E. J., Liu, Z., Khamaisi, M., King, G. L., Klein, R., Klein, B. E. K., Hughes, T. M., Craft, S., Freedman, B. I., Bowden, D. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01922 · Cited by 515
Self-citationRenal Autoregulation in Health and Disease
Carlström, M., Wilcox, C. S., & Arendshorst, W. J. (2015) · Physiological Reviews · doi:10.1152/physrev.00042.2012 · Cited by 485
Lifetime Incidence of CKD Stages 3-5 in the United States
Grams, M. E., Chow, E. K. H., Segev, D. L., & Coresh, J. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.03.009 · Cited by 302
Inferring genetic ancestry: Opportunities, challenges, and implications
Royal, C. D., Novembre, J., Fullerton, S. M., Goldstein, D. B., Long, J. C., Bamshad, M. J., & Clark, A. G. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.03.011 · Cited by 271
The Apolipoprotein L1 (APOL1) Gene and Nondiabetic Nephropathy in African Americans
Freedman, B. I., Kopp, J. B., Langefeld, C. D., Genovese, G., Friedman, D. J., Nelson, G. W., Winkler, C. A., Bowden, D. W., & Pollak, M. R. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010070730 · Cited by 271
Self-citationEpidemiology of hypertensive kidney disease
Udani, S., Lazich, I., & Bakris, G. L. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.154 · Cited by 171
Textor, S. C., Gloviczki, M. L., Flessner, M. F., Calhoun, D. A., Glockner, J., Grande, J. P., McKusick, M. A., Cha, S. S., & Lerman, L. O. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.09.023 · Cited by 30
Metadata
- Authors
- Freedman, B. I., Hicks, P. J., Bostrom, M. A., Cunningham, M. E., Liu, Y., Divers, J., Kopp, J. B., Winkler, C. A., Nelson, G. W., Langefeld, C. D., & Bowden, D. W.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2009-04
- Volume
- 75
- Issue
- 7
- Pages
- 736-745
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W2058286579
- Cited by
- 189
- References
- 0
- FWCI
- 25.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.